MCAF and EMD With and Without CTG Wall Technique for the Treatment of Class III and IV Gingival recessions-a Randomized Control Trial

ConditionGingival Recession

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-60

SponsorKrishnadevaraya College of Dental Sciences & Hospital

About this trial

Research is to compare and evaluate the clinical outcomes of the Connective tissue graft wall technique with modified coronally advanced flap to improve root coverage and clinical attachment levels in Miller's class III and IV gingival recession.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Participants aged 18-60 years

Systemically healthy individuals

Participants with Miller's Class III and IV or Cairo's RT3 gingival recession in maxillary and mandibular anteriors.

Participants with Nordland and Tarnow's papillary recession of either I, II or III.

Disqualifiers

Grade III mobile teeth

Pathologically migrated teeth

Endodontically treated teeth

Open contacts

Trial design

Design model

Parallel

Treatments tested in this trial

Connective tissue graft wall technique
Procedure/Surgery
Harvested connective tissue graft will be placed over the exposed root surface like a wall to cover the gingival recession

Treatment groups

24 Participants

are divided into 2 treatment groups

Group A: Study groupExperimental treatment 1 intervention

Group B: Control groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

Root coverage

Mean root coverage Cairo's RT3 gingival recession treated with MCAF + CTG wall + EMD technique is non-inferior to MCAF + CTG + EMD in terms of root coverage.

Time frame

6 months

Secondary outcomes

Gingival health and evaluation

clinical attachment level

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Krishnadevaraya College of Dental Sciences & Hospital

Lead sponsor

Source ClinicalTrials.gov

Apply now